Guidelines for the Evaluation and Treatment of Muscle Dysfunction in Patients With Chronic Obstructive Pulmonary Disease;Normativa SEPAR sobre disfunción muscular de los pacientes con enfermedad pulmonar obstructiva crónica

Archivos de Bronconeumologia

Volumn 51, Issue 8, 2015, Pages 384-395

  Barreiro, Esther ^a,b   Bustamante, Víctor ^c,d   Cejudo, Pilar ^d   Gáldiz, Juan B ^b,c   Gea, Joaquim ^a,b   de Lucas, Pilar ^e   Martínez Llorens, Juana ^a,b   Ortega, Francisco ^b,d   Puente Maestu, Luis ^e   Roca, Josep ^b,f,g   Rodríguez González Moro, José Miguel ^e  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL DE BASURTO   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

Author keywords

Chronic obstructive pulmonary disease; Muscle dysfunction; Spanish guidelines

Indexed keywords

ARTICLE; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; COMORBIDITY; DISEASE SEVERITY; HUMAN; MUSCLE DISEASE; MUSCLE STRENGTH; NUTRITIONAL SUPPORT; POPULATION RESEARCH; PRACTICE GUIDELINE; QUADRICEPS FEMORIS MUSCLE; QUALITY OF LIFE; TREATMENT PLANNING; CYCLOERGOMETRY; DIAGNOSTIC TEST; ELECTROMYOGRAM; ENDURANCE TRAINING; ERGOMETRY; EVIDENCE BASED MEDICINE; EXERCISE; EXERCISE TOLERANCE; GRADING OF RECOMMENDATIONS ASSESSMENT DEVELOPMENT AND EVALUATION SCALE; HORMONAL THERAPY; LIMB MUSCLE; MUSCLE MASS; MUSCLE TRAINING; NONINVASIVE VENTILATION; NUTRITION; PATHOPHYSIOLOGY; RATING SCALE; SIX MINUTE WALK TEST; SKELETAL MUSCLE; SPIROMETRY; BREATHING EXERCISE; COMPLICATION; ELECTRODIAGNOSIS; ENDURANCE; EXERCISE TEST; FEMALE; HAND STRENGTH; IMPEDANCE; KINESIOTHERAPY; MALE; MALNUTRITION; MUSCLE WEAKNESS;

ANABOLIC AGENT; GHRELIN; GROWTH HORMONE; HELIOX; HELIUM; HUMAN GROWTH HORMONE; OXYGEN; STEROID;

BREATHING EXERCISES; ELECTRIC IMPEDANCE; ELECTRODIAGNOSIS; EVIDENCE-BASED MEDICINE; EXERCISE TEST; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; GHRELIN; HAND STRENGTH; HELIUM; HUMAN GROWTH HORMONE; HUMANS; MALE; MALNUTRITION; MUSCLE WEAKNESS; NUTRITIONAL SUPPORT; OXYGEN; PHYSICAL ENDURANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY MUSCLES; SPIROMETRY; STEROIDS;

EID: 84938288144     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2015.04.027     Document Type: Article

References (166)

1. Guyatt G., Oxman A.D., Akl E.A., Kunz R., Vist G., Brozek J., et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011, 64:383-394.
2. Maltais F., Decramer M., Casaburi R., Barreiro E., Burelle Y., Debigare R., et al. An official American Thoracic Society/European Respiratory Society statement: Update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014, 189:e15-e62.
3. Gea J., Agusti A., Roca J. Pathophysiology of muscle dysfunction in COPD. J Appl Physiol (1985). 2013, 114:1222-1234.
4. Seymour J.M., Spruit M.A., Hopkinson N.S., Natanek S.A., Man W.D., Jackson A., et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010, 36:81-88.
5. Swallow E.B., Reyes D., Hopkinson N.S., Man W.D., Porcher R., Cetti E.J., et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax. 2007, 62:115-120.
6. Barreiro E., de la Puente B., Minguella J., Corominas J.M., Serrano S., Hussain S.N., et al. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005, 171:1116-1124.
7. Levine S., Kaiser L., Leferovich J., Tikunov B. Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med. 1997, 337:1799-1806.
8. Marin-Corral J., Minguella J., Ramirez-Sarmiento A.L., Hussain S.N., Gea J., Barreiro E. Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients. Eur Respir J. 2009, 33:1309-1319.
9. Fermoselle C., Rabinovich R., Ausin P., Puig-Vilanova E., Coronell C., Sanchez F., et al. Does oxidative stress modulate limb muscle atrophy in severe COPD patients?. Eur Respir J. 2012, 40:851-862.
10. Gosker H.R., Zeegers M.P., Wouters E.F., Schols A.M. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: A systematic review and meta-analysis. Thorax. 2007, 62:944-949.
11. Maltais F., LeBlanc P., Simard C., Jobin J., Berube C., Bruneau J., et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996, 154:442-447.
12. Remels A.H., Gosker H.R., Langen R.C., Schols A.M. The mechanisms of cachexia underlying muscle dysfunction in COPD. J Appl Physiol(1985). 2013, 114:1253-1262.
13. Barreiro E., Peinado V.I., Galdiz J.B., Ferrer E., Marin-Corral J., Sanchez F., et al. Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am J Respir Crit Care Med. 2010, 182:477-488.
14. Barreiro E., del Puerto-Nevado L., Puig-Vilanova E., Perez-Rial S., Sanchez F., Martinez-Galan L., et al. Cigarette smoke-induced oxidative stress in skeletal muscles of mice. Respir Physiol Neurobiol 2012, 182:9-17.
15. Barreiro E., Rabinovich R., Marin-Corral J., Barbera J.A., Gea J., Roca J. Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD. Thorax. 2009, 64:13-19.
16. Barreiro E., Ferrer D., Sanchez F., Minguella J., Marin-Corral J., Martinez-Llorens J., et al. Inflammatory cells and apoptosis in respiratory and limb muscles of patients with COPD. J Appl Physiol (1985). 2011, 111:808-817.
17. Puig-Vilanova E., Ausin P., Martinez-Llorens J., Gea J., Barreiro E. Do epigenetic events take place in the vastus lateralis of patients with mild chronic obstructive pulmonary disease?. PLoS One. 2014, 9:e102296.
18. Puig-Vilanova E., Rodriguez D.A., Lloreta J., Ausin P., Pascual-Guardia S., Broquetas J., et al. Oxidative stress, redox signaling pathways, and autophagy in cachectic muscles of male patients with advanced COPD and lung cancer. Free Radic Biol Med. 2015, 79:91-108.
19. Puig-Vilanova E., Martínez-Llorens J., Ausin P., Roca J., Gea J., Barreiro E. Quadriceps muscle weakness and atrophy are associated with a differential epigenetic profile in advanced COPD. Clin Sci. 2015, 128:905-921.
20. Similowski T., Yan S., Gauthier A.P., Macklem P.T., Bellemare F. Contractile properties of the human diaphragm during chronic hyperinflation. N Engl J Med. 1991, 325:917-923.
21. Doucet M., Debigare R., Joanisse D.R., Cote C., LeBlanc P., Gregoire J., et al. Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD. Eur Respir J. 2004, 24:971-979.
22. Orozco-Levi M., Gea J., Lloreta J.L., Felez M., Minguella J., Serrano S., et al. Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur Respir J. 1999, 13:371-378.
23. Orozco-Levi M., Lloreta J., Minguella J., Serrano S., Broquetas J.M., Gea J. Injury of the human diaphragm associated with exertion and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001, 164:1734-1739.
24. Ribera F., N'Guessan B., Zoll J., Fortin D., Serrurier B., Mettauer B., et al. Mitochondrial electron transport chain function is enhanced in inspiratory muscles of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003, 167:873-879.
25. Wijnhoven J.H., Janssen A.J., van Kuppevelt T.H., Rodenburg R.J., Dekhuijzen P.N. Metabolic capacity of the diaphragm in patients with COPD. Respir Med. 2006, 100:1064-1071.
26. Puig-Vilanova E., Aguilo R., Rodriguez-Fuster A., Martinez-Llorens J., Gea J., Barreiro E. Epigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary disease. PLoS One. 2014, 9:e111514.
27. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002, 166:518-624.
28. Garcia-Rio F., Calle M., Burgos F., Casan P., del Campo F., Galdiz J.B., et al. Spirometry. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Arch Bronconeumol 2013, 49:388-401.
29. Farrero E., Anton A., Egea C.J., Almaraz M.J., Masa J.F., Utrabo I., et al. Guidelines for the management of respiratory complications in patients with neuromuscular disease. Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Arch Bronconeumol. 2013, 49:306-313.
30. Morales P., Sanchis J., Cordero P.J., Diez J.L. Maximum static respiratory pressures in adults. The reference values for a Mediterranean Caucasian population. Arch Bronconeumol. 1997, 33:213-219.
31. Polkey M.I., Green M., Moxham J. Measurement of respiratory muscle strength. Thorax. 1995, 50:1131-1135.
32. Martinez-Llorens J., Ausin P., Roig A., Balana A., Admetllo M., Munoz L., et al. Nasal inspiratory pressure: An alternative for the assessment of inspiratory muscle strength?. Arch Bronconeumol. 2011, 47:169-175.
33. Laroche C.M., Carroll N., Moxham J., Green M. Clinical significance of severe isolated diaphragm weakness. Am Rev Respir Dis. 1988, 138:862-866.
34. Steier J., Kaul S., Seymour J., Jolley C., Rafferty G., Man W., et al. The value of multiple tests of respiratory muscle strength. Thorax. 2007, 62:975-980.
35. Bai T.R., Rabinovitch B.J., Pardy R.L. Near-maximal voluntary hyperpnea and ventilatory muscle function. J Appl Physiol Respir Environ Exerc Physiol. 1984, 57:1742-1748.
36. Martyn J.B., Moreno R.H., Pare P.D., Pardy R.L. Measurement of inspiratory muscle performance with incremental threshold loading. Am Rev Respir Dis. 1987, 135:919-923.
37. Orozco-Levi M., Gea J., Ferrer A., Mendez R., Ramirez-Sarmiento A., Maldonado D., et al. Expiratory muscle endurance in middle-aged healthy subjects. Lung. 2001, 179:93-103.
38. Ramirez-Sarmiento A., Orozco-Levi M., Barreiro E., Mendez R., Ferrer A., Broquetas J., et al. Expiratory muscle endurance in chronic obstructive pulmonary disease. Thorax. 2002, 57:132-136.
39. Ramirez-Sarmiento A., Orozco-Levi M., Guell R., Barreiro E., Hernandez N., Mota S., et al. Inspiratory muscle training in patients with chronic obstructive pulmonary disease: Structural adaptation and physiologic outcomes. Am J Respir Crit Care Med. 2002, 166:1491-1497.
40. Cattrysse E., Zinzen E., Caboor D., Duquet W., van Roy P., Clarys J.P. Anthropometric fractionation of body mass: Matiegka revisited. J Sports Sci. 2002, 20:717-723.
41. Schols A.M., Wouters E.F., Soeters P.B., Westerterp K.R. Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 1991, 53:421-424.
42. Lukaski H.C., Johnson P.E., Bolonchuk W.W., Lykken G.I. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr. 1985, 41:810-817.
43. Kim J., Wang Z., Heymsfield S.B., Baumgartner R.N., Gallagher D. Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr. 2002, 76:378-383.
44. Marquis K., Debigare R., Lacasse Y., LeBlanc P., Jobin J., Carrier G., et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002, 166:809-813.
45. Mathur S., Takai K.P., Macintyre D.L., Reid D. Estimation of thigh muscle mass with magnetic resonance imaging in older adults and people with chronic obstructive pulmonary disease. Phys Ther. 2008, 88:219-230.
46. Seymour J.M., Ward K., Sidhu P.S., Puthucheary Z., Steier J., Jolley C.J., et al. Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD. Thorax. 2009, 64:418-423.
47. Hayot M., Michaud A., Koechlin C., Caron M.A., LeBlanc P., Prefaut C., et al. Skeletal muscle microbiopsy: A validation study of a minimally invasive technique. Eur Respir J. 2005, 25:431-440.
48. Coggan A.R. Muscle biopsy as a tool in the study of aging. J Gerontol A Biol Sci Med Sci. 1995, 50:30-34.
49. Pitta F., Troosters T., Probst V.S., Spruit M.A., Decramer M., Gosselink R. Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J. 2006, 27:1040-1055.
50. Lenman J.A.R. Clinical Neurophysiology 1975, Blackwell Scientific Publications, Oxford.
51. Roussos C., Aubier M. Neural drive and electromechanical alterations in the fatiguing diaphragm. Human Muscle Fatigue: Physiological Mechanisms. Ciba Foundation Symposium 82 ed 1981, Pitman Medical London.
52. Walton J.N. Disorders of the Voluntary Muscle 1980, Curchil Livingstone, Edimburg. 4th ed.
53. Yoon Y., Mansour J., Simon S.R. Muscle activities during gait. Orthop Trans. 1981, 5:229-231.
54. Puhan M.A., Siebeling L., Zoller M., Muggensturm P., ter Riet G. Simple functional performance tests and mortality in COPD. Eur Respir J. 2013, 42:956-963.
55. Spruit M.A., Sillen M.J., Groenen M.T., Wouters E.F., Franssen F.M. New normative values for handgrip strength: Results from the UK Biobank. J Am Med Dir Assoc. 2013, 14:775-811.
56. Luna-Heredia E., Martin-Pena G., Ruiz-Galiana J. Handgrip dynamometry in healthy adults. Clin Nutr. 2005, 24:250-258.
57. Edwards R.H., Young A., Hosking G.P., Jones D.A. Human skeletal muscle function: Description of tests and normal values. Clin Sci Mol Med. 1977, 52:283-290.
58. Stevens J.E., Binder-Macleod S., Snyder-Mackler L. Characterization of the human quadriceps muscle in active elders. Arch Phys Med Rehabil. 2001, 82:973-978.
59. Coronell C., Orozco-Levi M., Mendez R., Ramirez-Sarmiento A., Galdiz J.B., Gea J. Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J. 2004, 24:129-136.
60. Malaguti C., Napolis L.M., Villaca D., Neder J.A., Nery L.E., dal Corso S. Relationship between peripheral muscle structure and function in patients with chronic obstructive pulmonary disease with different nutritional status. J Strength Cond Res. 2011, 25:1795-1803.
61. Man W.D., Soliman M.G., Gearing J., Radford S.G., Rafferty G.F., Gray B.J., et al. Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003, 168:562-567.
62. Polkey M.I., Kyroussis D., Hamnegard C.H., Mills G.H., Green M., Moxham J. Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man. Muscle Nerve. 1996, 19:549-555.
63. ATS Statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002, 166:111-117.
64. Wasserman K., Hansen J.E., Sue D.Y., Stringer W.W., Whipp B.J., Sietsema K.E., et al. Principles of Exercise Testing and Interpretation 2012, Lippincott Williams & Wilkins, Philadelphia. 5th ed.
65. Weisman I.M., Zeballos R.J. An integrated approach to the interpretation of cardiopulmonary exercise testing. Clin Chest Med. 1994, 15:421-445.
66. Holland A.E., Hill C.J., Rasekaba T., Lee A., Naughton M.T., McDonald C.F. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2010, 91:221-225.
67. Keyser R.E., Woolstenhulme J.G., Chin L.M., Nathan S.D., Weir N.A., Connors G., et al. Cardiorespiratory function before and after aerobic exercise training in patients with interstitial lung disease. J Cardiopulm Rehabil Prev. 2015, 35:47-55.
68. Mainguy V., Malenfant S., Neyron A.S., Saey D., Maltais F., Bonnet S., et al. Alternatives to the six-minute walk test in pulmonary arterial hypertension. PLoS One. 2014, 9:e103626.
69. Polkey M.I., Spruit M.A., Edwards L.D., Watkins M.L., Pinto-Plata V., Vestbo J., et al. Six-minute-walk test in chronic obstructive pulmonary disease: Minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med. 2013, 187:382-386.
70. Puhan M.A., Chandra D., Mosenifar Z., Ries A., Make B., Hansel N.N., et al. The minimal important difference of exercise tests in severe COPD. Eur Respir J. 2011, 37:784-790.
71. Rastogi D., Khan U.I., Isasi C.R., Coupey S.M. Associations of obesity and asthma with functional exercise capacity in urban minority adolescents. Pediatr Pulmonol. 2012, 47:1061-1069.
72. Tabata M., Shimizu R., Kamekawa D., Kato M., Kamiya K., Akiyama A., et al. Six-minute walk distance is an independent predictor of hospital readmission in patients with chronic heart failure. Int Heart J. 2014, 55:331-336.
73. Fletcher G.F., Balady G., Froelicher V.F., Hartley L.H., Haskell W.L., Pollock M.L. Exercise standards. A statement for healthcare professionals from the American Heart Association. Writing Group. Circulation. 1995, 91:580-615.
74. Pina I.L., Balady G.J., Hanson P., Labovitz A.J., Madonna D.W., Myers J. Guidelines for clinical exercise testing laboratories. A statement for healthcare professionals from the Committee on Exercise and Cardiac Rehabilitation, American Heart Association. Circulation. 1995, 91:912-921.
75. Hernandes N.A., Wouters E.F., Meijer K., Annegarn J., Pitta F., Spruit M.A. Reproducibility of 6-minute walking test in patients with COPD. Eur Respir J. 2011, 38:261-267.
76. Casanova C., Cote C., Marin J.M., Pinto-Plata V., de Torres J.P., Aguirre-Jaime A., et al. Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest. 2008, 134:746-752.
77. Forman D.E., Fleg J.L., Kitzman D.W., Brawner C.A., Swank A.M., McKelvie R.S., et al. 6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure. J Am Coll Cardiol. 2012, 60:2653-2661.
78. Garcia-Rio F., Lores V., Mediano O., Rojo B., Hernanz A., Lopez-Collazo E., et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med. 2009, 180:506-512.
79. Hasin T., Topilsky Y., Kremers W.K., Boilson B.A., Schirger J.A., Edwards B.S., et al. Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survival. Am J Cardiol. 2012, 110:1322-1328.
80. Pinto-Plata V.M., Cote C., Cabral H., Taylor J., Celli B.R. The 6-min walk distance: Change over time and value as a predictor of survival in severe COPD. Eur Respir J. 2004, 23:28-33.
81. Swigris J.J., Wamboldt F.S., Behr J., du Bois R.M., King T.E., Raghu G., et al. The 6minute walk in idiopathic pulmonary fibrosis: Longitudinal changes and minimum important difference. Thorax. 2010, 65:173-177.
82. Casas A., Vilaro J., Rabinovich R., Mayer A., Barbera J.A., Rodriguez-Roisin R., et al. Encouraged 6-min walking test indicates maximum sustainable exercise in COPD patients. Chest. 2005, 128:55-61.
83. Blanco I., Villaquiran C., Valera J.L., Molina-Molina M., Xaubet A., Rodriguez-Roisin R., et al. Peak oxygen uptake during the six-minute walk test in diffuse interstitial lung disease and pulmonary hypertension. Arch Bronconeumol. 2010, 46:122-128.
84. Neder J.A., Jones P.W., Nery L.E., Whipp B.J. Determinants of the exercise endurance capacity in patients with chronic obstructive pulmonary disease. The power-duration relationship. Am J Respir Crit Care Med. 2000, 162:497-504.
85. Holland A.E., Nici L. The return of the minimum clinically important difference for 6-minute-walk distance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013, 187:335-336.
86. Enright P.L., Sherrill D.L. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998, 158:1384-1387.
87. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003, 167:211-277.
88. Andrianopoulos V., Wagers S.S., Groenen M.T., Vanfleteren L.E., Franssen F.M., Smeenk F.W., et al. Characteristics and determinants of endurance cycle ergometry and six-minute walk distance in patients with COPD. BMC Pulm Med. 2014, 14:97.
89. Guazzi M., Adams V., Conraads V., Halle M., Mezzani A., Vanhees L., et al. EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012, 126:2261-2274.
90. Palange P., Ward S.A., Carlsen K.H., Casaburi R., Gallagher C.G., Gosselink R., et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J. 2007, 29:185-209.
91. Carter R., Riantawan P., Banham S.W., Sturrock R.D. An investigation of factors limiting aerobic capacity in patients with ankylosing spondylitis. Respir Med. 1999, 93:700-708.
92. Eschenbacher W.L., Mannina A. An algorithm for the interpretation of cardiopulmonary exercise tests. Chest. 1990, 97:263-267.
93. Ganju A.A., Fuladi A.B., Tayade B.O., Ganju N.A. Cardiopulmonary exercise testing in evaluation of patients of chronic obstructive pulmonary disease. Indian J Chest Dis Allied Sci. 2011, 53:87-91.
94. McNicholl D.M., Megarry J., McGarvey L.P., Riley M.S., Heaney L.G. The utility of cardiopulmonary exercise testing in difficult asthma. Chest. 2011, 139:1117-1123.
95. Medinger A.E., Chan T.W., Arabian A., Rohatgi P.K. Interpretive algorithms for the symptom-limited exercise test: Assessing dyspnea in Persian Gulf war veterans. Chest. 1998, 113:612-618.
96. Messner-Pellenc P., Ximenes C., Brasileiro C.F., Mercier J., Grolleau R., Prefaut C.G. Cardiopulmonary exercise testing. Determinants of dyspnea due to cardiac or pulmonary limitation. Chest. 1994, 106:354-360.
97. Plankeel J.F., McMullen B., MacIntyre N.R. Exercise outcomes after pulmonary rehabilitation depend on the initial mechanism of exercise limitation among non-oxygen-dependent COPD patients. Chest. 2005, 127:110-116.
98. Sexauer W.P., Cheng H.K., Fiel S.B. Utility of the breathing reserve index at the anaerobic threshold in determining ventilatory-limited exercise in adult cystic fibrosis patients. Chest. 2003, 124:1469-1475.
99. Fihn S.D., Gardin J.M., Abrams J., Berra K., Blankenship J.C., Dallas A.P., et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery. Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012, 60:e44-e164.
100. Roca J., Whipp B.J. Clinical Exercise Testing 1997, Lausanne. 1st ed.
101. Hansen J.E., Sun X.G., Yasunobu Y., Garafano R.P., Gates G., Barst R.J., et al. Reproducibility of cardiopulmonary exercise measurements in patients with pulmonary arterial hypertension. Chest. 2004, 126:816-824.
102. McKone E.F., Barry S.C., FitzGerald M.X., Gallagher C.G. Reproducibility of maximal exercise ergometer testing in patients with cystic fibrosis. Chest. 1999, 116:363-368.
103. Noseda A., Carpiaux J.P., Prigogine T., Schmerber J. Lung function, maximum and submaximum exercise testing in COPD patients: Reproducibility over a long interval. Lung. 1989, 167:247-257.
104. Keteyian S.J., Brawner C.A., Ehrman J.K., Ivanhoe R., Boehmer J.P., Abraham W.T. Reproducibility of peak oxygen uptake and other cardiopulmonary exercise parameters: implications for clinical trials and clinical practice. Chest. 2010, 138:950-955.
105. O'Donnell D.E., Travers J., Webb K.A., He Z., Lam Y.M., Hamilton A., et al. Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD. Eur Respir J. 2009, 34:866-874.
106. Davies E.J., Moxham T., Rees K., Singh S., Coats A.J., Ebrahim S., et al. Exercise based rehabilitation for heart failure. Cochrane Database Syst Rev. 2010, CD003331.
107. Casaburi R., Patessio A., Ioli F., Zanaboni S., Donner C.F., Wasserman K. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis. 1991, 143:9-18.
108. Chan L., Chin L.M., Kennedy M., Woolstenhulme J.G., Nathan S.D., Weinstein A.A., et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest. 2013, 143:333-343.
109. De Jong W., Grevink R.G., Roorda R.J., Kaptein A.A., van der Schans C.P. Effect of a home exercise training program in patients with cystic fibrosis. Chest. 1994, 105:463-468.
110. Neder J.A., Nery L.E., Silva A.C., Cabral A.L., Fernandes A.L. Short-term effects of aerobic training in the clinical management of moderate to severe asthma in children. Thorax. 1999, 54:202-206.
111. Puente-Maestu L., Sanz M.L., Sanz P., Cubillo J.M., Mayol J., Casaburi R. Comparison of effects of supervised versus self-monitored training programmes in patients with chronic obstructive pulmonary disease. Eur Respir J. 2000, 15:517-525.
112. Benzo R.P., Paramesh S., Patel S.A., Slivka W.A., Sciurba F.C. Optimal protocol selection for cardiopulmonary exercise testing in severe COPD. Chest. 2007, 132:1500-1505.
113. Puente-Maestu L., Villar F., de Miguel J., Stringer W.W., Sanz P., Sanz M.L., et al. Clinical relevance of constant power exercise duration changes in COPD. Eur Respir J. 2009, 34:340-345.
114. Spruit M.A., Singh S.J., Garvey C., ZuWallack R., Nici L., Rochester C., et al. An official American Thoracic Society/European Respiratory Society statement: Key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013, 188:e13-e64.
115. Andrianopoulos V., Klijn P., Franssen F.M., Spruit M.A. Exercise training in pulmonary rehabilitation. Clin Chest Med. 2014, 35:313-322.
116. Guell Rous M.R., Diaz L.S., Rodriguez T.G., Morante V.F., San M.M., Cejudo P., et al. Pulmonary rehabilitation. Arch Bronconeumol. 2014, 50:332-344.
117. Bolton C.E., Bevan-Smith E.F., Blakey J.D., Crowe P., Elkin S.L., Garrod R., et al. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 2013, 68:ii1-ii30.
118. Guell M.R., Cejudo P., Rodriguez-Trigo G., Galdiz J.B., Casolive V., Regueiro M., et al. Standards for quality care in respiratory rehabilitation in patients with chronic pulmonary disease. Quality Healthcare Committee. Spanish Society of Pneumology and Thoracic Surgery (SEPAR). Arch Bronconeumol. 2012, 48:396-404.
119. Puente-Maestu L., Tena T., Trascasa C., Perez-Parra J., Godoy R., Garcia M.J., et al. Training improves muscle oxidative capacity and oxygenation recovery kinetics in patients with chronic obstructive pulmonary disease. Eur J Appl Physiol. 2003, 88:580-587.
120. Vogiatzis I., Terzis G., Stratakos G., Cherouveim E., Athanasopoulos D., Spetsioti S., et al. Effect of pulmonary rehabilitation on peripheral muscle fiber remodeling in patients with COPD in GOLD stages II to IV. Chest. 2011, 140:744-752.
121. Vogiatzis I., Terzis G., Nanas S., Stratakos G., Simoes D.C., Georgiadou O., et al. Skeletal muscle adaptations to interval training in patients with advanced COPD. Chest. 2005, 128:3838-3845.
122. Beauchamp M.K., Janaudis-Ferreira T., Goldstein R.S., Brooks D. Optimal duration of pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease - a systematic review. Chron Respir Dis. 2011, 8:129-140.
123. Beauchamp M.K., Nonoyama M., Goldstein R.S., Hill K., Dolmage T.E., Mathur S., et al. Interval versus continuous training in individuals with chronic obstructive pulmonary disease - a systematic review. Thorax. 2010, 65:157-164.
124. Vogiatzis I., Nanas S., Roussos C. Interval training as an alternative modality to continuous exercise in patients with COPD. Eur Respir J. 2002, 20:12-19.
125. Ortega F., Toral J., Cejudo P., Villagomez R., Sanchez H., Castillo J., et al. Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002, 166:669-674.
126. Sillen M.J., Franssen F.M., Gosker H.R., Wouters E.F., Spruit M.A. Metabolic and structural changes in lower-limb skeletal muscle following neuromuscular electrical stimulation: A systematic review. PLoS One. 2013, 8:e69391.
127. Sillen M.J., Franssen F.M., Delbressine J.M., Vaes A.W., Wouters E.F., Spruit M.A. Efficacy of lower-limb muscle training modalities in severely dyspnoeic individuals with COPD and quadriceps muscle weakness: Results from the DICES trial. Thorax. 2014, 69:525-531.
128. Bustamante V., Lopez de Santa M.E., Gorostiza A., Jimenez U., Galdiz J.B. Muscle training with repetitive magnetic stimulation of the quadriceps in severe COPD patients. Respir Med. 2010, 104:237-245.
129. Gosselink R., de Vos J., van den Heuvel S.P., Segers J., Decramer M., Kwakkel G. Impact of inspiratory muscle training in patients with COPD: What is the evidence?. Eur Respir J. 2011, 37:416-425.
130. Laveneziana P., Palange P. Physical activity, nutritional status and systemic inflammation in COPD. Eur Respir J. 2012, 40:522-529.
131. Raguso C.A., Luthy C. Nutritional status in chronic obstructive pulmonary disease: Role of hypoxia. Nutrition. 2011, 27:138-143.
132. Vermeeren M.A., Creutzberg E.C., Schols A.M., Postma D.S., Pieters W.R., Roldaan A.C., et al. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med. 2006, 100:1349-1355.
133. Ferreira I.M., Brooks D., White J., Goldstein R. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012, 12:CD000998.
134. Ali T., Bennoor K.S., Begum N. Effects of nutritional modification on anthropometry and lung functions of COPD patients. Chest. 2007, 132:532-538.
135. Efthimiou J., Fleming J., Gomes C., Spiro S.G. The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1988, 137:1075-1082.
136. Fuenzalida C.E., Petty T.L., Jones M.L., Jarrett S., Harbeck R.J., Terry R.W., et al. The immune response to short-term nutritional intervention in advanced chronic obstructive pulmonary disease. Am Rev Respir Dis. 1990, 142:49-56.
137. Goris A.H., Vermeeren M.A., Wouters E.F., Schols A.M., Westerterp K.R. Energy balance in depleted ambulatory patients with chronic obstructive pulmonary disease: The effect of physical activity and oral nutritional supplementation. Br J Nutr. 2003, 89:725-731.
138. Hoogendoorn M., van Wetering C.R., Schols A.M., Rutten-van Molken M.P. Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective?. Eur Respir J. 2010, 35:79-87.
139. Knowles J.B., Fairbarn M.S., Wiggs B.J., Chan-Yan C., Pardy R.L. Dietary supplementation and respiratory muscle performance in patients with COPD. Chest. 1988, 93:977-983.
140. Lewis M.I., Belman M.J., Dorr-Uyemura L. Nutritional supplementation in ambulatory patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1987, 135:1062-1068.
141. Otte K.E., Ahlburg P., d'Amore F., Stellfeld M. Nutritional repletion in malnourished patients with emphysema. JPEN J Parenter Enteral Nutr. 1989, 13:152-156.
142. Rogers R.M., Donahoe M., Costantino J. Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary disease. A randomized control study. Am Rev Respir Dis. 1992, 146:1511-1517.
143. Schols A.M., Soeters P.B., Mostert R., Pluymers R.J., Wouters E.F. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med. 1995, 152:1268-1274.
144. Steiner M.C., Barton R.L., Singh S.J., Morgan M.D. Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: A randomised controlled trial. Thorax. 2003, 58:745-751.
145. Sugawara K., Takahashi H., Kasai C., Kiyokawa N., Watanabe T., Fujii S., et al. Effects of nutritional supplementation combined with low-intensity exercise in malnourished patients with COPD. Respir Med. 2010, 104:1883-1889.
146. Sugawara K., Takahashi H., Kashiwagura T., Yamada K., Yanagida S., Homma M., et al. Effect of anti-inflammatory supplementation with whey peptide and exercise therapy in patients with COPD. Respir Med. 2012, 106:1526-1534.
147. Weekes C.E., Emery P.W., Elia M. Dietary counselling and food fortification in stable COPD: A randomised trial. Thorax. 2009, 64:326-331.
148. Whittaker J.S., Ryan C.F., Buckley P.A., Road J.D. The effects of refeeding on peripheral and respiratory muscle function in malnourished chronic obstructive pulmonary disease patients. Am Rev Respir Dis. 1990, 142:283-288.
149. Samaras N., Samaras D., Chambellan A., Pichard C., Thibault R. Pulmonary rehabilitation: The reference therapy for undernourished patients with chronic obstructive pulmonary disease. Biomed Res Int. 2014, 2014:248420.
150. Burdet L., de Muralt B., Schutz Y., Pichard C., Fitting J.W. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am J Respir Crit Care Med. 1997, 156:1800-1806.
151. Casaburi R., Bhasin S., Cosentino L., Porszasz J., Somfay A., Lewis M.I., et al. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004, 170:870-878.
152. Creutzberg E.C., Wouters E.F., Mostert R., Pluymers R.J., Schols A.M. A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Chest. 2003, 124:1733-1742.
153. Ferreira I.M., Verreschi I.T., Nery L.E., Goldstein R.S., Zamel N., Brooks D., et al. The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest. 1998, 114:19-28.
154. Sharma S., Arneja A., McLean L., Duerksen D., Leslie W., Sciberras D., et al. Anabolic steroids in COPD: A review and preliminary results of a randomized trial. Chron Respir Dis. 2008, 5:169-176.
155. Svartberg J., Aasebo U., Hjalmarsen A., Sundsfjord J., Jorde R. Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial. Respir Med. 2004, 98:906-913.
156. Pison C.M., Cano N.J., Cherion C., Caron F., Court-Fortune, Antonini M.T., et al. Multimodal nutritional rehabilitation improves clinical outcomes of malnourished patients with chronic respiratory failure: A randomised controlled trial. Thorax. 2011, 66:953-960.
157. Pape G.S., Friedman M., Underwood L.E., Clemmons D.R. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. Chest. 1991, 99:1495-1500.
158. DeBoer M.D. Ghrelin and cachexia: Will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?. Mol Cell Endocrinol. 2011, 340:97-105.
159. Itoh M., Tsuji T., Nemoto K., Nakamura H., Aoshiba K. Undernutrition in patients with COPD and its treatment. Nutrients. 2013, 5:1316-1335.
160. Nagaya N., Itoh T., Murakami S., Oya H., Uematsu M., Miyatake K., et al. Treatment of cachexia with ghrelin in patients with COPD. Chest. 2005, 128:1187-1193.
161. Miki K., Maekura R., Nagaya N., Nakazato M., Kimura H., Murakami S., et al. Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: A multicenter, randomized, double-blind, placebo-controlled trial. PLoS One. 2012, 7:e35708.
162. Miki K., Maekura R., Nagaya N., Kitada S., Miki M., Yoshimura K., et al. Effects of ghrelin treatment on exercise capacity in underweight COPD patients: A substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment. BMC Pulm Med. 2013, 13:37.
163. Deacon S.J., Vincent E.E., Greenhaff P.L., Fox J., Steiner M.C., Singh S.J., et al. Randomized controlled trial of dietary creatine as an adjunct therapy to physical training in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008, 178:233-239.
164. Fuld J.P., Kilduff L.P., Neder J.A., Pitsiladis Y., Lean M.E., Ward S.A., et al. Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax. 2005, 60:531-537.
165. Borghi-Silva A., di Thommazo L., Pantoni C.B., Mendes R.G., Salvini T.F., Costa D. Non-invasive ventilation improves peripheral oxygen saturation and reduces fatigability of quadriceps in patients with COPD. Respirology. 2009, 14:537-544.
166. Moga A.M., de Marchie M., Saey D., Spahija J. Mechanisms of non-pharmacologic adjunct therapies used during exercise in COPD. Respir Med. 2012, 106:614-626.